{"id":"https://openalex.org/W4362543374","doi":"https://doi.org/10.1158/1538-7445.am2023-2792","title":"Abstract 2792: Development of pharmacodynamic assays for quantifying SMARCA2 protein degradation and target gene expression in response to a SMARCA2 degrader (PRT3789)","display_name":"Abstract 2792: Development of pharmacodynamic assays for quantifying SMARCA2 protein degradation and target gene expression in response to a SMARCA2 degrader (PRT3789)","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362543374","doi":"https://doi.org/10.1158/1538-7445.am2023-2792"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-2792","doi":"https://doi.org/10.1158/1538-7445.am2023-2792","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-2792","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101927522","display_name":"Andrew Moore","orcid":"https://orcid.org/0009-0005-4080-5676","observed_orcids":["https://orcid.org/0009-0005-4080-5676"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Moore","raw_affiliation_strings":["1Prelude Therapeutics Incorporated, Wilmington, DE;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics Incorporated, Wilmington, DE;","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022388072","display_name":"Carly Bachner","orcid":"https://orcid.org/0009-0005-3855-5612","observed_orcids":["https://orcid.org/0009-0005-3855-5612"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carly Bachner","raw_affiliation_strings":["1Prelude Therapeutics Incorporated, Wilmington, DE;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics Incorporated, Wilmington, DE;","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060868364","display_name":"Lalitha Srinivasan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164526","display_name":"Meso Scale Discovery (United States)","ror":"https://ror.org/05jgy0m16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210164526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lalitha Srinivasan","raw_affiliation_strings":["2Meso Scale Discovery, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Meso Scale Discovery, Rockville, MD","institution_ids":["https://openalex.org/I4210164526"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Pradeep Kurup","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164526","display_name":"Meso Scale Discovery (United States)","ror":"https://ror.org/05jgy0m16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210164526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pradeep Kurup","raw_affiliation_strings":["2Meso Scale Discovery, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Meso Scale Discovery, Rockville, MD","institution_ids":["https://openalex.org/I4210164526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069730078","display_name":"Alexander Grego","orcid":"https://orcid.org/0009-0000-8724-7003","observed_orcids":["https://orcid.org/0009-0000-8724-7003"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Grego","raw_affiliation_strings":["1Prelude Therapeutics Incorporated, Wilmington, DE;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics Incorporated, Wilmington, DE;","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033928827","display_name":"Caroline Vitkovitsky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caroline Vitkovitsky","raw_affiliation_strings":["1Prelude Therapeutics Incorporated, Wilmington, DE;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics Incorporated, Wilmington, DE;","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023093205","display_name":"Koichi Ito","orcid":"https://orcid.org/0000-0003-1421-3122","observed_orcids":["https://orcid.org/0000-0003-1421-3122"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Koichi Ito","raw_affiliation_strings":["1Prelude Therapeutics Incorporated, Wilmington, DE;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics Incorporated, Wilmington, DE;","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060435781","display_name":"Neha Bhagwat","orcid":"https://orcid.org/0009-0002-5766-0272","observed_orcids":["https://orcid.org/0009-0002-5766-0272"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neha Bhagwat","raw_affiliation_strings":["1Prelude Therapeutics Incorporated, Wilmington, DE;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics Incorporated, Wilmington, DE;","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018193992","display_name":"Peggy Scherle","orcid":"https://orcid.org/0000-0003-0783-6815","observed_orcids":["https://orcid.org/0000-0003-0783-6815"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peggy Scherle","raw_affiliation_strings":["1Prelude Therapeutics Incorporated, Wilmington, DE;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics Incorporated, Wilmington, DE;","institution_ids":["https://openalex.org/I4405265449"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"2792","last_page":"2792"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.024800000712275505,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/protein-degraders","display_name":"protein degraders","score":0.7440000176429749},{"id":"https://openalex.org/keywords/pharmacodynamic-assay","display_name":"pharmacodynamic assay","score":0.7699999809265137},{"id":"https://openalex.org/keywords/target-engagement","display_name":"target engagement","score":0.9150000214576721},{"id":"https://openalex.org/keywords/swi-snf-complex","display_name":"SWI/SNF complex","score":0.9330000281333923},{"id":"https://openalex.org/keywords/peripheral-blood-mononuclear-cells","display_name":"peripheral blood mononuclear cells","score":0.9620000123977661},{"id":"https://openalex.org/keywords/immunoassay","display_name":"immunoassay","score":0.6639999747276306},{"id":"https://openalex.org/keywords/differential-gene-expression","display_name":"differential gene expression","score":0.718999981880188},{"id":"https://openalex.org/keywords/gene-panel","display_name":"gene panel","score":0.4480000138282776},{"id":"https://openalex.org/keywords/chromatin-remodeling","display_name":"chromatin remodeling","score":0.5019999742507935}],"concepts":[{"id":"https://openalex.org/C80828422","wikidata":"https://www.wikidata.org/wiki/Q18031595","display_name":"SMARCA4","level":5,"score":0.9060934782028198},{"id":"https://openalex.org/C2992195973","wikidata":"https://www.wikidata.org/wiki/Q33123","display_name":"Protein degradation","level":2,"score":0.5340465903282166},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.4874172508716583},{"id":"https://openalex.org/C134320426","wikidata":"https://www.wikidata.org/wiki/Q901026","display_name":"Chromatin immunoprecipitation","level":5,"score":0.4442077875137329},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.44303274154663086},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4311002194881439},{"id":"https://openalex.org/C167227067","wikidata":"https://www.wikidata.org/wiki/Q5113739","display_name":"Chromatin remodeling","level":4,"score":0.3989366292953491},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.36454224586486816},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3287324905395508},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.25998762249946594},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11887297034263611},{"id":"https://openalex.org/C101762097","wikidata":"https://www.wikidata.org/wiki/Q224093","display_name":"Promoter","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-2792","doi":"https://doi.org/10.1158/1538-7445.am2023-2792","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-2792","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389239771","https://openalex.org/W4282925667","https://openalex.org/W4389240577","https://openalex.org/W4414465618","https://openalex.org/W4393085484","https://openalex.org/W4402560061","https://openalex.org/W4409625770","https://openalex.org/W4409689517","https://openalex.org/W4387811462","https://openalex.org/W4393071848"],"abstract_inverted_index":{"Abstract":[0],"The":[1],"SWI/SNF":[2],"complex":[3],"plays":[4],"an":[5,179,261],"important":[6],"role":[7],"in":[8,24,52,83,94,100,129,134,163,268,277,327,366],"controlling":[9],"gene":[10,132,219,287,296,364],"expression":[11,133,220,267,288,293,365],"via":[12],"chromatin":[13],"remodeling.":[14],"One":[15],"of":[16,63,76,114,149,161,174,211,225,294,312,354,376],"its":[17],"catalytic":[18,37],"subunits,":[19],"SMARCA4,":[20],"is":[21],"frequently":[22],"mutated":[23],"multiple":[25],"tumor":[26],"types,":[27],"and":[28,66,79,127,152,191,204,274,310,362,389],"SMARCA4-deficient":[29],"cells":[30,138],"are":[31],"highly":[32],"dependent":[33],"on":[34,292],"the":[35,61,142,147,158,200,308,377],"other":[36],"subunit,":[38],"SMARCA2,":[39],"for":[40,146,156,176,246,357,380],"survival.":[41],"Therefore,":[42],"targeting":[43],"SMARCA2":[44,68,77,124,130,162,177,212,226,301,359,370],"with":[45,102,178,244,300],"selective":[46,67],"protein":[47,78,125,159,227,302,360],"degraders":[48],"has":[49],"therapeutic":[50],"potential":[51],"SMARCA4":[53],"deficient":[54],"human":[55,135,164,238],"cancers.":[56],"We":[57,140,259,282],"have":[58],"previously":[59],"described":[60],"development":[62,148,309],"a":[64,95,150,170,223,231,285,369],"potent":[65],"targeted":[69],"degrader,":[70],"PRT3789,":[71,115],"that":[72,264,298,319],"demonstrates":[73],"robust":[74,266],"degradation":[75,126,361],"excellent":[80],"preclinical":[81],"efficacy":[82],"SMARCA4-del":[84],"models":[85],"(Hulse,":[86],"et":[87],"al.":[88],"2022).":[89],"PRT3789":[90,245,280,331],"will":[91],"be":[92,321],"evaluated":[93],"Phase":[96],"1":[97,387],"clinical":[98,112],"trial":[99],"patients":[101],"SMARCA4-mutant":[103],"cancer.":[104],"In":[105,196,214,304],"order":[106,215],"to":[107,122,194,207,216,254,279,323,368],"assess":[108],"target":[109,131,325,363],"engagement":[110,326],"following":[111,330],"administration":[113],"we":[116,198,229,306],"developed":[117,230],"two":[118,313],"pharmacodynamic":[119,355],"(PD)":[120],"assays":[121,318,356],"measure":[123],"changes":[128,221,276],"peripheral":[136],"mononuclear":[137],"(PBMCs).":[139],"used":[141,322],"MSD\u00ae":[143],"S-PLEX":[144],"platform":[145],"sensitive":[151,209],"quantitative,":[153],"plate-based":[154],"immunoassay":[155],"determining":[157],"concentration":[160],"PBMC":[165,201],"lysates.":[166],"This":[167],"assay":[168],"exhibits":[169],"wide":[171],"dynamic":[172],"range":[173],"detection":[175,210],"LLOD":[180],"at":[181],"1.5":[182],"pg/mL,":[183],"as":[184,186,222,270,272],"well":[185,271],"exhibiting":[187],"acceptable":[188],"spike":[189],"recovery":[190],"minimal":[192],"cross-reactivity":[193],"SMARCA4.":[195],"addition,":[197],"optimized":[199],"isolation":[202],"protocol":[203],"lysis":[205],"conditions":[206],"enable":[208],"protein.":[213],"demonstrate":[217],"downstream":[218],"consequence":[224],"degradation,":[228],"secondary":[232],"qPCR":[233],"assay.":[234],"PBMCs":[235],"from":[236],"healthy":[237],"donors":[239],"were":[240],"treated":[241],"ex":[242],"vivo":[243],"24":[247],"-":[248],"48":[249],"hours,":[250],"followed":[251],"by":[252],"RNA-sequencing":[253],"identify":[255],"differentially":[256],"expressed":[257],"genes.":[258],"refined":[260],"8-gene":[262],"panel":[263,297],"showed":[265],"PBMCs,":[269],"consistent":[273],"dose-dependent":[275],"response":[278,367],"treatment.":[281],"further":[283],"calculated":[284],"differential":[286],"(DGE)":[289],"score":[290],"based":[291],"this":[295],"correlates":[299],"degradation.":[303],"summary,":[305],"describe":[307],"characterization":[311],"independent":[314],"clinically":[315],"relevant":[316],"PD":[317],"can":[320],"evaluate":[324],"blood":[328],"samples":[329],"administration.":[332],"Citation":[333],"Format:":[334],"Andrew":[335],"Moore,":[336],"Carly":[337],"Bachner,":[338],"Lalitha":[339],"Srinivasan,":[340],"Pradeep":[341],"Kurup,":[342],"Alex":[343],"Grego,":[344],"Caroline":[345],"Vitkovitsky,":[346],"Koichi":[347],"Ito,":[348],"Neha":[349],"Bhagwat,":[350],"Peggy":[351],"Scherle.":[352],"Development":[353],"quantifying":[358],"degrader":[371],"(PRT3789)":[372],"[abstract].":[373],"In:":[374],"Proceedings":[375],"American":[378],"Association":[379],"Cancer":[381,400],"Research":[382],"Annual":[383],"Meeting":[384],"2023;":[385],"Part":[386],"(Regular":[388],"Invited":[390],"Abstracts);":[391],"2023":[392],"Apr":[393],"14-19;":[394],"Orlando,":[395],"FL.":[396],"Philadelphia":[397],"(PA):":[398],"AACR;":[399],"Res":[401],"2023;83(7_Suppl):Abstract":[402],"nr":[403],"2792.":[404]},"counts_by_year":[],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2023-04-06T00:00:00"}